Skip to main content
Premium Trial:

Request an Annual Quote

Geneka, Genomatix Enter Functional Genomics, Tech Development Alliance

NEW YORK, Oct. 23 – Canadian proteomic firm Geneka Biotechnology and Genomatix Software, a bioinformatics company based in Munich, Germany, have inked a researcher alliance that focuses on functional genomics and technology development, Geneka said on Tuesday.

The partnership, which will span eight to 10 years, initially will be a drug-discovery alliance that will center on human proteomic regulators, according to Geneka. Other parts of the deal, which were not specified, have to do with technology development, said Denis Goyette, Geneka’s director of finance.

Goyette said that an undisclosed product based on technology already developed by the alliance is expected to reach the market in the current quarter. That product, he said, will be marketed in the United States, Europe, and Japan.

Financial terms of the agreement were disclosed.

Geneka currently markets the P.R.O.M. DNA microarray chip, which carries probes for all known or suspected human transcription regulators available from public genome sequences. Genomatix Software will provide proprietary bioinformatics services to analyze the data generated by P.R.O.M.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.